Clinical Trial Update: Clinical Study of Z-213 in Subjects With Iron-deficiency Anemia [Phase 3]

View source ↗

Summary

Update on a Phase 3 clinical study of Z-213 for iron-deficiency anemia. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• Z-213

Snippet

Sponsor: Zeria Pharmaceutical | Conditions: Iron Deficiency Anemia | Phase 3 | Status: COMPLETED